BACKGROUND: Many studies have shown that exposures to air pollution are associated with cardiovascular events, although the mechanism remains to be clarified. To identify whether exposures to ambient particles act on autonomic function via the lipid/endothelial metabolism pathway, whether effects of particulate matter <2.5 mum in aerodynamic diameter (PM(2.5)) on heart rate variability (HRV) were modified by gene polymorphisms related to those pathways were evaluated. METHODS: HRV and gene data from the Normative Aging Study and PM(2.5) from a monitor located a kilometre from the examination site were used. A mixed model was fitted to investigate the associations between PM(2.5) and repeated measurements of HRV by gene polymorphisms of apolipoprotein E (APOE), lipoprotein lipase (LPL) and vascular endothelial growth factor (VEGF) adjusting for potential confounders chosen a priori. RESULTS: A 10 microg/m(3) increase in PM(2.5) in the 2 days before the examination was associated with 3.8% (95% CI 0.2% to 7.4%), 7.8% (95 CI 0.4% to 15.3%) and 10.6% (95% CI 1.8% to 19.4%) decreases of the standard deviation of normal-to-normal intervals, the low frequency and the high frequency, respectively. Overall, carriers of wild-type APOE, LPL and VEGF genes had stronger effects of particles on HRV than those with hetero- or homozygous types. Variations of LPL-N291S, LPL-D9N and APOE-G113C significantly modified effects of PM(2.5) on HRV. CONCLUSION: Associations between PM(2.5) and HRV were modified by gene polymorphisms of APOE, LPL and VEGF; the biological metabolism remains to be identified.
BACKGROUND: Many studies have shown that exposures to air pollution are associated with cardiovascular events, although the mechanism remains to be clarified. To identify whether exposures to ambient particles act on autonomic function via the lipid/endothelial metabolism pathway, whether effects of particulate matter <2.5 mum in aerodynamic diameter (PM(2.5)) on heart rate variability (HRV) were modified by gene polymorphisms related to those pathways were evaluated. METHODS: HRV and gene data from the Normative Aging Study and PM(2.5) from a monitor located a kilometre from the examination site were used. A mixed model was fitted to investigate the associations between PM(2.5) and repeated measurements of HRV by gene polymorphisms of apolipoprotein E (APOE), lipoprotein lipase (LPL) and vascular endothelial growth factor (VEGF) adjusting for potential confounders chosen a priori. RESULTS: A 10 microg/m(3) increase in PM(2.5) in the 2 days before the examination was associated with 3.8% (95% CI 0.2% to 7.4%), 7.8% (95 CI 0.4% to 15.3%) and 10.6% (95% CI 1.8% to 19.4%) decreases of the standard deviation of normal-to-normal intervals, the low frequency and the high frequency, respectively. Overall, carriers of wild-type APOE, LPL and VEGF genes had stronger effects of particles on HRV than those with hetero- or homozygous types. Variations of LPL-N291S, LPL-D9N and APOE-G113C significantly modified effects of PM(2.5) on HRV. CONCLUSION: Associations between PM(2.5) and HRV were modified by gene polymorphisms of APOE, LPL and VEGF; the biological metabolism remains to be identified.
Authors: P W Reymer; E Gagné; B E Groenemeyer; H Zhang; I Forsyth; H Jansen; J C Seidell; D Kromhout; K E Lie; J Kastelein Journal: Nat Genet Date: 1995-05 Impact factor: 38.330
Authors: Gray T Malcom; C Alex McMahan; Henry C McGill; Edward E Herderick; Richard E Tracy; Dana A Troxclair; Jack P Strong Journal: Atherosclerosis Date: 2008-07-12 Impact factor: 5.162
Authors: C Tikellis; K A Jandeleit-Dahm; K Sheehy; A Murphy; J Chin-Dusting; D Kling; E Sebokova; M E Cooper; J Mizrahi; K J Woollard Journal: Atherosclerosis Date: 2008-02-21 Impact factor: 5.162
Authors: Amanda J Churchill; James G Carter; Conor Ramsden; Steven J Turner; Anna Yeung; Paul E C Brenchley; David W Ray Journal: Invest Ophthalmol Vis Sci Date: 2008-04-25 Impact factor: 4.799
Authors: P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy Journal: Nature Date: 1996-04-04 Impact factor: 49.962
Authors: F Mailly; Y Tugrul; P W Reymer; T Bruin; M Seed; B F Groenemeyer; A Asplund-Carlson; D Vallance; A F Winder; G J Miller Journal: Arterioscler Thromb Vasc Biol Date: 1995-04 Impact factor: 8.311
Authors: Cizao Ren; Sung Kyun Park; Pantel S Vokonas; David Sparrow; Elissa Wilker; Andrea Baccarelli; Helen H Suh; Katherine L Tucker; Robert O Wright; Joel Schwartz Journal: Epidemiology Date: 2010-03 Impact factor: 4.822
Authors: Cizao Ren; Marie S O'Neill; Sung Kyun Park; David Sparrow; Pantel Vokonas; Joel Schwartz Journal: Am J Epidemiol Date: 2011-03-08 Impact factor: 4.897
Authors: Victor C Van Hee; Sara D Adar; Adam A Szpiro; R Graham Barr; Ana Diez Roux; David A Bluemke; Lianne Sheppard; Edward A Gill; Hossein Bahrami; Christina Wassel; Michele M Sale; David S Siscovick; Jerome I Rotter; Stephen S Rich; Joel D Kaufman Journal: Environ Health Perspect Date: 2010-03-22 Impact factor: 9.031
Authors: Cizao Ren; Pantel S Vokonas; Helen Suh; Shona Fang; David C Christiani; Joel Schwartz Journal: Environ Health Date: 2010-12-07 Impact factor: 5.984
Authors: Marie-Abele Bind; Brent Coull; Helen Suh; Robert Wright; Andrea Baccarelli; Pantel Vokonas; Joel Schwartz Journal: PLoS One Date: 2014-04-22 Impact factor: 3.240
Authors: Natalie M Johnson; Aline Rodrigues Hoffmann; Jonathan C Behlen; Carmen Lau; Drew Pendleton; Navada Harvey; Ross Shore; Yixin Li; Jingshu Chen; Yanan Tian; Renyi Zhang Journal: Environ Health Prev Med Date: 2021-07-12 Impact factor: 3.674